VIRAL INTERLEUKIN-10 IS CRITICAL FOR THE INDUCTION OF B-CELL GROWTH TRANSFORMATION BY EPSTEIN-BARR-VIRUS

被引:129
作者
MIYAZAKI, I
CHEUNG, RK
DOSCH, HM
机构
[1] UNIV TORONTO,HOSP SICK CHILDREN,RES INST,DEPT PEDIAT,DIV IMMUNOL & CANC,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA
[2] UNIV TORONTO,HOSP SICK CHILDREN,RES INST,DEPT IMMUNOL,TORONTO M5G 1X8,ONTARIO,CANADA
关键词
D O I
10.1084/jem.178.2.439
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have used an efficient cDNA subtraction library procedure to identify newly induced genes in human B lymphocytes infected for 6 h with Epstein-Barr virus (EBV). Among the genes identified by automated sequencing of a random subset of clones from this library, one coded the EBV BCRF1 open reading frame, which specifies the viral interleukin 10 gene (vIL-10). This molecule is highly homologous to human (h)IL-10 and was previously thought to represent a ''late'' viral gene expressed only during the lytic phase of virus replication. Using gene amplification by reverse transcriptase polymerase chain reaction of B cell RNA obtained at varying times after infection, we detected vIL-10 expression within a few hours of EBV infection, followed, 20-30 h later by expression of hIL-10. Expression of both genes continued beyond the initial transformation phase (5-10 d) and was present in all transformed cell lines tested. When added at the time of viral infection, antisense (but not sense) oligonucleotides for vIL-10 mRNA (cytosolic half-life, approximately 6 h) prevented subsequent B cell transformation. The antisense effect was highly specific, leaving the expression levels of other transformation-related genes intact. Addition of exogenous (h)IL-10 rescued the transformation process in antisense-treated cells. Our observations establish vIL-10 as a new latency gene with a directly transformation-prerequisite function.
引用
收藏
页码:439 / 447
页数:9
相关论文
共 50 条
[11]  
CHEUNG RK, 1993, BIOTECHNIQUES, V14, P785
[12]  
CHEUNG RK, 1993, IN PRESS INT J IMMUN
[13]  
COOPER NR, 1988, ANNU REV IMMUNOL, V6, P85
[14]  
DING L, 1992, J IMMUNOL, V148, P3133
[15]   EBV UTILIZES A UNIQUE ACTIVATION PATHWAY FOR THE TRANSFORMATION OF HUMAN B-CELLS [J].
DOSCH, HM ;
LAM, P ;
HUI, MF ;
HIBI, T ;
CHEUNG, RK .
INTERNATIONAL IMMUNOLOGY, 1990, 2 (09) :833-848
[16]   EXOGENOUS BUT NOT ENDOGENOUS EBV INDUCES LYMPHOMAS IN BEIGE NUDE XID MICE CARRYING HUMAN LYMPHOID XENOGRAFTS [J].
DOSCH, HM ;
COCHRANE, DMG ;
COOK, VA ;
LEEDER, JS ;
CHEUNG, RK .
INTERNATIONAL IMMUNOLOGY, 1991, 3 (07) :731-735
[17]   DIAGNOSIS OF NASOPHARYNGEAL CARCINOMA BY DNA AMPLIFICATION OF TISSUE OBTAINED BY FINE-NEEDLE ASPIRATION [J].
FEINMESSER, R ;
MIYAZAKI, I ;
CHEUNG, R ;
FREEMAN, JL ;
NOYEK, AM ;
DOSCH, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (01) :17-21
[18]  
FINKE J, 1992, BLOOD, V80, P459
[19]   TRANS-ACTING REQUIREMENTS FOR REPLICATION OF EPSTEIN-BARR-VIRUS ORI-LYT [J].
FIXMAN, ED ;
HAYWARD, GS ;
HAYWARD, SD .
JOURNAL OF VIROLOGY, 1992, 66 (08) :5030-5039
[20]  
GOLAY JT, 1987, IMMUNOLOGY, V62, P279